Natural killer cells: from bench to cancer therapy

Michael Boyiadzis1, Kenneth A Foon

  • 1University of Pittsburgh Cancer Institute, Division of Hematology/Oncology, Department of Medicine, University of Pittsburgh School of Medicine, UPMC Cancer Pavilion, 5150 Centre Avenue, Suite 572, Pittsburgh, PA 15232, USA. boyiadzism@upmc.edu

Insights

Natural killer (NK) cells are crucial for fighting viruses and tumors. Recent advances in understanding NK cell biology and interleukin-15 are paving the way for improved NK cell immunotherapies in cancer treatment.

Area of Science:

  • Immunology
  • Oncology
  • Cellular Biology

Background:

  • Natural killer (NK) cells are key components of the innate immune system.
  • NK cells combat viral infections and tumors via cytokine production and direct cell killing.
  • Previous clinical trials using activated NK cells for cancer yielded limited success.

Purpose of the Study:

  • To explore novel strategies for cancer immunotherapy utilizing NK cells.
  • To leverage advancements in NK cell biology and receptor function.
  • To investigate the role of interleukin-15 in enhancing NK cell activity for therapeutic purposes.

Main Methods:

  • Reviewing recent developments in NK cell biology and receptor signaling.
  • Analyzing the impact of interleukin-15 on NK cell activation and function.
  • Evaluating new therapeutic strategies in both transplant and non-transplant settings.

Main Results:

  • A deeper understanding of NK cell mechanisms has emerged.
  • Interleukin-15 has been identified as a critical factor in NK cell-mediated immunity.
  • New therapeutic approaches are being developed based on these findings.

Conclusions:

  • Enhanced knowledge of NK cell biology is driving innovation in cancer immunotherapy.
  • Targeted strategies involving NK cells show promise for treating cancer.
  • Further research is ongoing to optimize NK cell-based therapies.

Related Concept Videos

Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cells of the Innate Immune Response01:28

Cells of the Innate Immune Response

The innate immune response is an immediate and non-specific response against pathogens, acting swiftly to prevent the spread of infections. The primary cells involved in this response are phagocytes and natural killer (NK) cells.
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...